Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 84,283 | 96,869 | 97,097 | 91,260 | 91,346 |
| Cost of Goods | 70,984 | 79,466 | 72,444 | 69,898 | 71,500 |
| Gross Profit | 13,299 | 17,403 | 24,653 | 21,362 | 19,846 |
| Operating Expenses | 11,904 | 19,099 | 10,518 | 9,502 | 9,876 |
| Operating Income | 2,379 | -1,230 | 14,579 | 12,758 | 10,470 |
| Interest Expense | 1,976 | 2,000 | 2,000 | 1,943 | 1,978 |
| Pre-tax Income | 403 | -3,230 | 12,579 | 10,815 | 8,492 |
| Income Tax | 169 | -904 | 3,522 | 3,028 | 2,378 |
| Net Income Continuous | 234 | -2,326 | 9,057 | 7,787 | 6,114 |
| Net Income | $-16,458 | $-2,326 | $9,057 | $7,787 | $6,114 |
| EPS Basic Total Ops | -0.25 | -0.04 | 0.14 | 0.12 | 0.10 |
| EPS Basic Continuous Ops | 0.01 | -0.04 | 0.14 | 0.12 | 0.10 |
| EPS Diluted Total Ops | -0.25 | -0.04 | 0.14 | 0.12 | 0.09 |
| EPS Diluted Continuous Ops | 0.01 | -0.04 | 0.13 | 0.11 | 0.09 |
| EBITDA(a) | $2,379 | $4,552 | $20,585 | $18,496 | $16,023 |